Invited Speaker, Metastatic Castration Sensitive Prostate Cancer: Recent Strides in Drug and Biomarker Development, Hematology-Oncology, Grand Rounds, Stephenson Cancer Center, University of Oklahoma, March 19, 2021.
Invited Speaker, Metastatic Castration Sensitive Prostate Cancer, Institutional Perspective on Prostate Cancer, University of Washington, OncLive State of Science Summit, November 24, 2020.
Invited Speaker, Emerging Role of PARP Inhibitors in Prostate Cancer, Prime Oncology CME, Prime Education LLC, Fort Lauderdale, FL (Virtual), October 31, 2020.
Invited Speaker, The Universe of Castration Sensitive Prostate Cancer, UroTarget 2020, Argentina Oncology Association (AAOC), October 31, 2020.
Invited Speaker, Updates in the Management of Advanced Prostate Cancer and Personalizing Therapy, Grand Rounds, Fred Hutchinson Cancer Research Center, University of Washington, October 5, 2020.
Invited Speaker, Updates in Prostate Cancer, ASCO Direct UAE 2020 Webinar, Genitourinary Oncology, Emirates Oncology Society, Abu Dhabi, UAE, October 3, 2020.
Invited Speaker, Opinions in Bladder Cancer, Curio Science, Denver CO (Virtual), September 30, 2020.
Invited Speaker, Systemic Therapy of Low Volume Metastatic Castration Sensitive Prostate Cancer, ONCO 2020, Society of Urology of Columbian/Ecuador/Peru, September 25, 2020.
Invited Speaker, National Congress, Molecular Medicine from Laboratory to Practice, Athens, Greece. March 12, 2020.
Invited Speaker, Tata Memorial Centre,18th Annual Conference on Evidence Based Management of Cancers in India, Uro Oncology- Decade of Transformation, Mumbai, India. February 28-March 1, 2020.
Oral Presentation, 2020 Genitourinary Cancer Symposium (GU ASCO). Time to Second Progression (PFS2) in Patients From TITAN With Metastatic Castration-Sensitive Prostate Cancer by First Subsequent Therapy (Hormonal vs Taxane). San Francisco, CA. February 13, 2020.
Oral Presentation, Health Related Quality of Life with Apalutamide in Phase 3 Titan trial. 11th European Multidisciplinary Congress in Urologic Cancers (EMUC), Vienna, Austria, November 16, 2019.
Invited Speaker, OnConnect (9th PCF) meeting. Sao Paulo, Brazil, August 16-17, 2019.
Invited Speaker, Oncology Grand Rounds. Saint Vincent’s Medical Center. Immunotherapeutic Strategies for Advanced Renal Cell Carcinoma.Bridgeport, CT.August 30, 2019.
Invited Speaker, Grand Rounds, Department of Internal Medicine, University of Utah, July 18, 2019.
Oral Presentation, 2019 ASCO Annual Meeting – Balancing Disease Control and Quality of Life in Metastatic Renal Cell Carcinoma. Chicago, IL. June 3, 2019.
Invited Speaker and Panelist, Juravinski and Walker Cancer Centres Uro-oncology Forum 2019. Niagra-On-The-Lake, ON, Canada. March 2, 2019.
Invited Speaker, Canadian Urology Association. Grand Round talks at McGill University Health Centre (MUHC), Centre hospitalier de I’Universite de Montreal (CHUM), Jewish Gerneral Hospital, London Regional Cancer Centre, Princess Margaret Cancer Centre (UHN). 2/27/19-3/01/19.
Invited Speaker and Chair, OncLive State of Science Summit, Motif Seattle. Seattle, WA. 12/13/18.
Invited Speaker, Cardinal Health Oncology Summit. Orlando, FL. November 11, 2018.
Invited Speaker and Session Moderator, 17th International Kidney Cancer Symposium, Kidney Cancer Association. Miami, FL. November 2-3, 2018.
Oral Presentation, 17th International Kidney Cancer Symposium, Kidney Cancer Association. CfDNA. Miami, FL. November 2, 2018.
Oral Presentation, 17th International Kidney Cancer Symposium, Kidney Cancer Association. Phase 1b Study (COSMIC-021) of Cabozantinib in Combination with Atezolizumab: Results of the Dose Escalation Stage in Patients with Treatment-Naïve Advanced Renal Cell Carcinoma (RCC). Miami, FL. November 3, 2018.
Oral Presentation, European Society of Medical Oncology (ESMO) 2018 Congress – Proffered (oral) Paper session, Translational Research Session- Pan-cancer assessment of BRCA1/2 genomic alterations (GAs) by comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA) (abstract 51O). Munich, Germany. October 20, 2018.
Invited Speaker and Session Chair, 2018 American Society of Clinical Oncology (ASCO 2018) Annual Meeting – Prostate Cancer Tumor Board, Education Session, Chicago, IL. June 4, 2018.
Invited Speaker, 2018 ASCO Pre-Annual Meeting Seminar Faculty Invitation – Cancer Immunotherapy Today: Maximizing Patient Outcomes. Immunotherapy Update in Genitourinary Oncology. June 1st, 2018.
Invited Speaker and Chair, 2018 Huntsman Cancer Institute Genitourinary Oncology Symposium, Salt Lake City, UT, May 25, 2018.
Invited Speaker and Chair, OncLive State of Science Summit, Little America Hotel, Salt Lake City, UT, May 24, 2018.
Invited Speaker, Targeted Oncology Conference, Napa, CA. March 16, 2018.
Invited Speaker, American Society of Clinical Onocolgy (ASCO) University Faculty Speaker (webcast), February 2018: Treatment of Castration Sensitive Metastatic Prostate Cancer.
Invited Speaker, Grand Rounds, Division of Nephrology and Hypertension, University of California, Irvine. November 27, 2017.